Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2016; 116(05): 1001
DOI: 10.1160/TH16-05-0396
DOI: 10.1160/TH16-05-0396
Author Correspondence
The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy
Further Information
Publication History
Received:
24 May 2016
Accepted after major revision:
07 June 2016
Publication Date:
30 November 2017 (online)

-
References
- 1 Camporese G, Bernardi E, Noventa F. et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thromb Haemost 2016; 116: 349-355.
- 2 Gaskill T, Pullen M, Bryant B. et al. The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction. Am JSports Med 2015; 43: 2714-2719.
- 3 Krych AJ, Sousa PL, Morgan JA. et al. Incidence and Risk Factor Analysis of Symptomatic Venous Thromboembolism After Knee Arthroscopy. Arthroscopy 2015 Epub ahead of print.
- 4 Mauck KF, Froehling DA, Daniels PR. et al. Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. JThrombHaemost 2013; 11: 1279-1286.